These medications exist to help people get healthier
While the multidistrict litigation initially focused on gastrointestinal injuries, the emergence of NAION claims has added a new dimension to the legal battle against drug manufacturers Novo Nordisk and other GLP-1 companies
Elevated VLDL (above 20 mg/dL) isnt just a cholesterol problemits a metabolic problem
Muscle loss with GLP-1RAs is probably proportional to the extent of weight loss, and resistance exercise with adequate protein intake is recommended to preserve muscle mass and function
While not FDA-approved as a finished drug, compounded semaglutide demonstrates equivalent clinical outcomes to brand versions when sourced from credible pharmacies, at significantly lower cost
An in vivo study in high-fat diet-fed mice indicates that a six-week administration of 18.5 nmol/kg GLP-1(28-36)amide improved hepatic glucose disposal, which is associated with increased cAMP levels and phosphorylation of PKA target [1]
